MK
Mark Kaye (EVP & CFO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Elevance Health, Inc. (ELV). The largest single filing was $4.6M of ELV (10,424 sh across 12 lots, as filed), executed Oct 22. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.6M
shares × price, as filed
Last traded
Oct 22
Filed Oct 23
Median ADV $656.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ELVRecent filings
ELVSALE
Elevance Health, Inc.
View filing →
$4.6M10,424 sh across 12 lots
Exec Oct 22
Filed Oct 23 · 4:30 PM ET ELVSALE Elevance Health, Inc. View filing → $1.9M
4,588 sh × $424.82
Exec Apr 24 2025
Filed Apr 25 2025 · 5:30 PM ET